Mirna21 Expression in the Breast Cancer Tumor Tissue is Independent of Neoadjuvant Chemotherapy

References

• FerlayJ, ColombetM, SoerjomataramI, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–1953. doi:10.1002/ijc.3193730350310
   PubMed Web of Science ®Google Scholar
• NelsonHD, ZakherB, CantorA, et al. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012;156(9):635–648. doi:10.7326/0003-4819-156-9-201205010-0000622547473
   PubMed Web of Science ®Google Scholar
• VishnoiA, RaniS. MiRNA Biogenesis and Regulation of Diseases: An Overview. InMicroRNA Profiling. Humana Press; 2017:1–10.
   Google Scholar
• ShahPP, HutchinsonLE, KakarSS. Emerging role of microRNAs in diagnosis and treatment of various diseases including ovarian cancer. J Ovarian Res. 2009;2(1):11. doi:10.1186/1757-2215-2-1119712461
   PubMed Web of Science ®Google Scholar
• ChenJQ, PappG, SzodorayP, et al. The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun Rev. 2016;15(12):1171–1180. doi:10.1016/j.autrev.2016.09.00327639156
   PubMed Web of Science ®Google Scholar
• PichlerM, CalinGA. MicroRNAs in cancer: from developmental genes in worms to their clinical application in patients. Br J Cancer. 2015;113(4):569. doi:10.1038/bjc.2015.25326158421
   PubMed Web of Science ®Google Scholar
• CortezMA, Bueso-RamosC, FerdinJ, et al. MicroRNAs in body fluids—the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8(8):467.21647195
   PubMed Web of Science ®Google Scholar
• CalinGA, CroceCM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857. doi:10.1038/nrc199717060945
   PubMed Web of Science ®Google Scholar
• GrimaldiAM, IncoronatoM. Clinical translatability of “identified” circulating miRNAs for diagnosing breast cancer: overview and update. Cancers. 2019;11(7):901. doi:10.3390/cancers11070901
   Web of Science ®Google Scholar
• VoliniaS, CalinGA, LiuCG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006;103(7):2257–2261. doi:10.1073/pnas.051056510316461460
   PubMed Web of Science ®Google Scholar
• LeeEJ, GusevY, JiangJ, et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2007;120(5):1046–1054.17149698
   PubMed Web of Science ®Google Scholar
• NamEJ, YoonH, KimSW, et al. MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008;14(9):2690–2695. doi:10.1158/1078-0432.CCR-07-173118451233
   PubMed Web of Science ®Google Scholar
• AsagaS, KuoC, NguyenT, et al. Direct serum assay for microRNA-21 concentrations in early and advanced breast cancer. Clin Chem. 2011;57(1):84–91. doi:10.1373/clinchem.2010.15184521036945
   PubMed Web of Science ®Google Scholar
• ChenJ, WangX. MicroRNA-21 in breast cancer: diagnostic and prognostic potential. Clin Transl Oncol. 2014;16(3):225–233. doi:10.1007/s12094-013-1132-z24248894
   PubMed Web of Science ®Google Scholar
• GiulianoAE, EdgeSB, HortobagyiGN. Eighth edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol. 2018;25(7):1783–1785. doi:10.1245/s10434-018-6486-629671136
   PubMed Web of Science ®Google Scholar
• LivakKJ, SchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25(4):402–408.11846609
   PubMed Web of Science ®Google Scholar
• IorioMV, FerracinM, LiuCG, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65(16):7065–7070. doi:10.1158/0008-5472.CAN-05-178316103053
   PubMed Web of Science ®Google Scholar
• SiML, ZhuS, WuH, et al. miR-21-mediated tumor growth. Oncogene. 2007;26(19):2799. doi:10.1038/sj.onc.121008317072344
   PubMed Web of Science ®Google Scholar
• BanKA, GodellasCV. Epidemiology of breast cancer. Surg Oncol Clin N Am. 2014;23(3):409–422. doi:10.1016/j.soc.2014.03.01124882341
   PubMed Web of Science ®Google Scholar
• dos-Santos-SilvaI, De StavolaBL, JuniorNL, et al. Ethnoracial and social trends in breast cancer staging at diagnosis in Brazil, 2001–14: a case only analysis. Lancet Glob Health. 2019;7(6):e784–97. doi:10.1016/S2214-109X(19)30151-231097280
   PubMed Web of Science ®Google Scholar
• LiCI, UribeDJ, DalingJR. Clinical characteristics of different histologic types of breast cancer. Br J Cancer. 2005;93(9):1046. doi:10.1038/sj.bjc.660278716175185
   PubMed Web of Science ®Google Scholar
• KumarN, PatniP, AgarwalA, et al. Prevalence of molecular subtypes of invasive breast cancer: a retrospective study. Med J Armed Forces India. 2015;71(3):254–258. doi:10.1016/j.mjafi.2015.04.00626288493
   PubMedGoogle Scholar
• Al-KhanbashiM, CaramutaS, AlajmiAM, et al. Tissue and serum mirna profile in locally advanced breast cancer (labc) in response to neo-adjuvant chemotherapy (nac) treatment. PLoS One. 2016;11(4):e0152032. doi:10.1371/journal.pone.015203227064979
   PubMed Web of Science ®Google Scholar
• García-VazquezR, Ruiz-GarcíaE, Meneses GarciaA, et al. A microRNA signature associated with pathological complete response to novel neoadjuvant therapy regimen in triple-negative breast cancer. Tumor Biol. 2017;39(6):1010428317702899. doi:10.1177/1010428317702899
   Google Scholar
• Luengo-GilG, García-MartínezE, Chaves-BenitoA, et al. Clinical and biological impact of miR-18a expression in breast cancer after neoadjuvant chemotherapy. Cell Oncol. 2019;21:1–8.
   Google Scholar
• RaychaudhuriM, BrongerH, BuchnerT, et al. MicroRNAs miR-7 and miR-340 predict response to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat. 2017;162(3):511–521. doi:10.1007/s10549-017-4132-928181130
   PubMed Web of Science ®Google Scholar
• ZhengY, LiS, BoohakerRJ, et al. A microRNA expression signature in taxane-anthracycline-based neoadjuvant chemotherapy response. J Cancer. 2015;6(7):671.26078798
   PubMed Web of Science ®Google Scholar
• HuangGL, ZhangXH, GuoGL, et al. Clinical significance of miR-21 expression in breast cancer: SYBR-green I-based real-time RT-PCR study of invasive ductal carcinoma. Oncol Rep. 2009;21(3):673–679.19212625
   PubMed Web of Science ®Google Scholar
• YanLX, HuangXF, ShaoQ, et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 2008;14(11):2348–2360.18812439
   PubMed Web of Science ®Google Scholar
• OzgunA, KaragozB, BilgiO, et al. MicroRNA-21 as an indicator of aggressive phenotype in breast câncer. Onkologie. 2013;36(3):115–118. doi:10.1159/00034867823485999
   PubMedGoogle Scholar
• WangF, ZhengZ, GuoJ, et al. Correlation and quantitation of microRNA aberrant expression in tissues and sera from patients with breast tumor. Gynecol Oncol. 2010;119(3):586–593.20801493
   PubMed Web of Science ®Google Scholar
• DongG, LiangX, WangD, et al. High expression of miR-21 in triple-negative breast cancers was correlated with a poor prognosis and promoted tumor cell in vitro proliferation. Med Oncol. 2014;31(7):57. doi:10.1007/s12032-014-0057-x24930006
   PubMed Web of Science ®Google Scholar
• SavadS, MehdipourP, MiryounesiM, et al. Expression analysis of MiR-21, MiR-205, and MiR-342 in breast cancer in Iran. Asian Pac J Cancer Prev. 2012;13(3):873–877. doi:10.7314/APJCP.2012.13.3.87322631664
   PubMedGoogle Scholar
• SempereLF, ChristensenM, SilahtarogluA, et al. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 2007;67(24):11612–11620. doi:10.1158/0008-5472.CAN-07-501918089790
   PubMed Web of Science ®Google Scholar
• SiH, SunX, ChenY, et al. Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol. 2013;139(2):223–229. doi:10.1007/s00432-012-1315-y23052693
   PubMed Web of Science ®Google Scholar
• SchwarzenbachH, Da SilvaAM, CalinG, et al. Data normalization strategies for microRNA quantification. Clin Chem. 2015;61(11):1333–1342.26408530
   PubMed Web of Science ®Google Scholar
• KokMG, HallianiA, MoerlandPD, et al. Normalization panels for the reliable quantification of circulating microRNAs by RT-qPCR. FASEB J. 2015;29(9):3853–3862. doi:10.1096/fj.15-27131226023181
   PubMed Web of Science ®Google Scholar
• KangK, PengX, LuoJ, et al. Identification of circulating miRNA biomarkers based on global quantitative real-time PCR profiling. J Anim Sci Biotechnol. 2012;3(1):4. doi:10.1186/2049-1891-3-422958414
   PubMed Web of Science ®Google Scholar
• ArabkariV, ClancyE, DwyerRM, et al. Relative and absolute expression analysis of micrornas associated with luminal a breast cancer–a comparison. Pathol Oncol Res. 2019;6:1–2.
   Google Scholar